Global DNA Methylation, Measured by the Luminometric Methylation Assay (LUMA), Associates with Postmenopausal Breast Cancer in Non-Obese and Physically Active Women

Journal of Cancer

Volumn 6, Issue 6, 2015, Pages 548-554

  McCullough, Lauren E ^a   Chen, Jia ^b   White, Alexandra J ^a   Xu, Xinran ^c   Cho, Yoon Hee ^d   Bradshaw, Patrick T ^a   Eng, Sybil M ^d   Teitelbaum, Susan L ^b   Terry, Mary Beth ^d   Garbowski, Gail ^d   Neugut, Alfred I ^d   Hibshoosh, Hanina ^d   Santella, Regina M ^d   Gammon, Marilie D ^a  

^a The University of North Carolina at Chapel Hill   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c First Affiliated Hospital of Fourth Military Medical University   (China)

^d Howard Hughes Medical Institute   (United States)

Author keywords

Breast cancer; Epidemiology; Global DNA methylation; Obesity; Physical activity

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BODY MASS; BODY SIZE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; DNA METHYLATION; FEMALE; HUMAN; LONG INTERSPERSED REPEAT; LUMINOMETRIC METHYLATION ASSAY; MAJOR CLINICAL STUDY; PHYSICAL ACTIVITY; POSTMENOPAUSE; RISK ASSESSMENT;

EID: 84930208739     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.11359     Document Type: Article

References (36)

1. Russo J, Yang X, Hu YF, Bove BA, Huang Y, Silva ID, Tahin Q, Wu Y, Higgy N, Zekri A, Russo IH. Biological and molecular basis of human breast cancer. Front Biosci 1998 Sep 1;3:D944-60.
2. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002 Jun;3(6):415-428.
3. Wilson AS, Power BE, Molloy PL. DNA hypomethylation and human diseases. Biochim Biophys Acta 2007 Jan;1775(1):138-162.
4. Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R. DNA hypomethylation leads to elevated mutation rates. Nature 1998 Sep 3;395(6697):89-93.
5. Ulrich CM, Grady WM. Linking epidemiology to epigenomics-where are we today?. Cancer Prev Res (Phila) 2010 Dec;3(12):1505-1508.
6. Friedenreich CM. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 2001 Feb;10(1):15-32.
7. Friedenreich CM. Physical activity and breast cancer: review of the epidemiologic evidence and biologic mechanisms. Recent Results Cancer Res 2011;188:125-139.
8. Feinberg AP, Irizarry RA, Fradin D, Aryee MJ, Murakami P, Aspelund T, Eiriksdottir G, Harris TB, Launer L, Gudnason V, Fallin MD. Personalized epigenomic signatures that are stable over time and covary with body mass index. Sci Transl Med 2010 Sep 15;2(49):49ra67.
9. Piyathilake C, Badiga S, Johanning G, Alvarez R, Partridge E. Predictors and health consequences of epigenetic changes associated with excess body weight in women of child-bearing age. Cancer Epidemiol Biomarkers Prev 2011;:719.
10. White AJ, Sandler DP, Bolick SC, Xu Z, Taylor JA, Deroo LA. Recreational and household physical activity at different time points and DNA global methylation. Eur J Cancer 2013 Jun;49(9):2199-2206.
11. Zhang FF, Cardarelli R, Carroll J, Zhang S, Fulda KG, Gonzalez K, Vishwanatha JK, Morabia A, Santella RM. Physical activity and global genomic DNA methylation in a cancer-free population. Epigenetics 2011 Mar;6(3):293-299.
12. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E, Ehrlich M, Laird PW. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 2005 Dec 2;33(21):6823-6836.
13. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 2004 Feb 18;32(3):e38.
14. Xu X, Gammon MD, Hernandez-Vargas H, Herceg Z, Wetmur JG, Teitelbaum SL, Bradshaw PT, Neugut AI, Santella RM, Chen J. DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population-based study. FASEB J 2012 Feb 27.
15. Gammon MD, Neugut AI, Santella RM, Teitelbaum SL, Britton JA, Terry MB, Eng SM, Wolff MS, Stellman SD, Kabat GC, Levin B, Bradlow HL, et al. The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat 2002 Jun;74(3):235-254.
16. Gammon MD, Santella RM, Neugut AI, Eng SM, Teitelbaum SL, Paykin A, Levin B, Terry MB, Young TL, Wang LW, Wang Q, Britton JA, et al. Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol Biomarkers Prev 2002 Aug;11(8):677-685.
17. Bjornsson HT, Sigurdsson MI, Fallin MD, Irizarry RA, Aspelund T, Cui H, Yu W, Rongione MA, Ekström TJ, Harris TB, Launer LJ, Eiriksdottir G, et al. Intra-individual change over time in DNA methylation with familial clustering. JAMA 2008 Jun 25;299(24):2877-2883.
18. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM, Statistics Subcommittee of NCI-EORTC Working Group on Cancer Diagnostics. REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat 2006 Nov;100(2):229-235.
19. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Danenberg PV, Laird PW. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res 1999 May 15;59(10):2302-2306.
20. Bernstein M, Sloutskis D, Kumanyika S, Sparti A, Schutz Y, Morabia A. Data-based approach for developing a physical activity frequency questionnaire. Am J Epidemiol 1998 Jan 15;147(2):147-154.
21. McCullough LE, Eng SM, Bradshaw PT, Cleveland RJ, Teitelbaum SL, Neugut AI, Gammon MD. Fat or fit: The joint effects of physical activity, weight gain, and body size on breast cancer risk. Cancer 2012 Oct 1;118(19):4860-4868.
22. Kleinbaum DG, Klein M. Logistic Regression: A Self-Learning Text. 2nd ed. New York: Springer; 2002.
23. Breslow NE, Day NE. Statistical methods in cancer research. Volume I-The analysis of case-control studies. IARC Sci Publ 1980;:5-338.
24. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989 Mar;79(3):340-349.
25. Terry MB, Delgado-Cruzata L, Vin-Raviv N, Wu HC, Santella RM. DNA methylation in white blood cells: association with risk factors in epidemiologic studies. Epigenetics 2011 Jul;6(7):828-837.
26. Christensen BC, Houseman EA, Marsit CJ, Zheng S, Wrensch MR, Wiemels JL, Nelson HH, Karagas MR, Padbury JF, Bueno R, Sugarbaker DJ, Yeh RF, et al. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet 2009 Aug;5(8):e1000602.
27. Hsiung DT, Marsit CJ, Houseman EA, Eddy K, Furniss CS, McClean MD, Kelsey KT. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2007 Jan;16(1):108-114.
28. Brennan K, Flanagan JM. Is there a link between genome-wide hypomethylation in blood and cancer risk?. Cancer Prev Res (Phila) 2012 Dec;5(12):1345-1357.
29. Delgado-Cruzata L, Wu HC, Perrin M, Liao Y, Kappil MA, Ferris JS, Flom JD, Yazici H, Santella RM, Terry MB. Global DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry. Epigenetics 2012 Aug;7(8):868-874.
30. Kuchiba A, Iwasaki M, Ono H, Kasuga Y, Yokoyama S, Onuma H, Nishimura H, Kusama R, Tsugane S, Yoshida T. Global methylation levels in peripheral blood leukocyte DNA by LUMA and breast cancer: a case-control study in Japanese women. Br J Cancer 2014 May 27;110(11):2765-2771.
31. Zhu ZZ, Hou L, Bollati V, Tarantini L, Marinelli B, Cantone L, Yang AS, Vokonas P, Lissowska J, Fustinoni S, Pesatori AC, Bonzini M, et al. Predictors of global methylation levels in blood DNA of healthy subjects: a combined analysis. Int J Epidemiol 2012 Feb;41(1):126-139.
32. Kim KY, Kim DS, Lee SK, Lee IK, Kang JH, Chang YS, Jacobs DR, Steffes M, Lee DH. Association of low-dose exposure to persistent organic pollutants with global DNA hypomethylation in healthy Koreans. Environ Health Perspect 2010 Mar;118(3):370-374.
33. Zhang FF, Santella RM, Wolff M, Kappil MA, Markowitz SB, Morabia A. White blood cell global methylation and IL-6 promoter methylation in association with diet and lifestyle risk factors in a cancer-free population. Epigenetics 2012 Jun 1;7(6):606-614.
34. Terry MB, Gammon MD, Zhang FF, Eng SM, Sagiv SK, Paykin AB, Wang Q, Hayes S, Teitelbaum SL, Neugut AI, Santella RM. Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2004 Dec;13(12):2053-2058.
35. Piyathilake CJ, Macaluso M, Alvarez RD, Chen M, Badiga S, Siddiqui NR, Edberg JC, Partridge EE, Johanning GL. A higher degree of LINE-1 methylation in peripheral blood mononuclear cells, a one-carbon nutrient related epigenetic alteration, is associated with a lower risk of developing cervical intraepithelial neoplasia. Nutrition 2011 May;27(5):513-519.
36. van Bemmel D, Lenz P, Liao LM, Baris D, Sternberg LR, Warner A, Johnson A, Jones M, Kida M, Schwenn M, Schned AR, Silverman DT, et al. Correlation of LINE-1 methylation levels in patient-matched buffy coat, serum, buccal cell, and bladder tumor tissue DNA samples. Cancer Epidemiol Biomarkers Prev 2012 Jul;21(7):1143-1148.